PE html>
<html>
<head>
<meta charset="UTF-8">
<title>Medical Illustration of Overgrowth Disorder: Art-Historical and Biomedical Analysis</title>
<style>
    body {
        font-family: Arial, sans-serif;
        margin: 40px;
        display: flex;
    }
    img {
        max-width: 30%;
        height: 100%;
        margin-right: 20px;
    }
    .content {
        max-width: 70%;
    }
</style>
</head>
<body>
<img src="../images/josephmerrick5jpgproteussyndrome.jpg" alt="Nineteenth-century medical illustration depicting craniofacial and thoracic asymmetry">
<div class="content">
    <h2>Medical Illustration of Overgrowth Disorder: Art-Historical and Biomedical Analysis</h2>

    <h3>[a] Artist/ Group/Tribe</h3>
    <p>
        The image is characteristic of late nineteenth-century medical illustration, likely produced by an anonymous clinical draughtsperson working for a hospital, pathology museum, or medical periodical. Such illustrators operated at the intersection of art and science, trained to render lesions, textures, and bodily proportions with descriptive precision. Their task was not portraiture in a traditional sense, but evidentiary depiction: to make the abnormality legible for physicians and students. The artist’s anonymity reflects the collaborative, institutional nature of medical image-making in the era, where the “author” was often the clinic rather than the individual.
    </p>

    <h3>[b] Historical and Socio-Cultural context (time-frame)</h3>
    <p>
        Circa 1870–1900, European and British medicine witnessed an expansion of pathology museums, atlases, and illustrated case reports. Technologies such as wood engraving, photomechanical reproduction, and later halftone printing allowed wider circulation of images of rare conditions. This coincided with a culture of public display—curiosity exhibitions and popular illustrated weeklies—blurring boundaries between scientific documentation and spectacle. The period also saw the consolidation of hospital charity systems and the professionalization of surgery, within a broader social milieu marked by industrial urbanization and the rise of classificatory sciences.
    </p>

    <h3>[c] Symbolism and/ or iconography</h3>
    <p>
        The profile view isolates asymmetry and overgrowth, a conventional pose in medical iconography for craniofacial conditions. The circular vignette frames the body like a specimen, signaling clinical containment and inviting comparative viewing across a series. Nudity is partial and functional rather than eroticized, intended to expose the topography of skin and bone. The absent background removes social context, translating the sitter into an anatomical problem to be read rather than a subject to be encountered.
    </p>

    <h3>[d] Stylistic Significance (elements of art/ principles of design)</h3>
    <p>
        Cross-hatching and stippling model volume and surface with high local contrast, an approach optimized for print legibility. Emphasis is created through directional lighting, which heightens the relief of bony protuberances and cutaneous irregularities. Asymmetrical balance structures the composition: the enlarged craniofacial mass on one side is counterweighted by negative space on the other. Line quality is descriptive rather than expressive, aligning with the epistemic ideal of “mechanical objectivity” sought by nineteenth-century scientific images.
    </p>

    <h3>[e] Social / Cultural Inequities</h3>
    <p>
        Images like this sit within a history of disability as spectacle, where impoverished or marginalized patients could find their bodies circulated without robust consent norms. Class disparities shaped who entered teaching hospitals and who became visible in medical print. Such representation often decontextualized subjects from their lives, reinscribing ableist hierarchies by presenting difference as anomaly. Contemporary readings must acknowledge this legacy and strive for ethical viewing that restores personhood and resists exploitation.
    </p>

    <h3>[f] Description of Disease & Etiology</h3>
    <p>
        The formal features evoke disorders of segmental overgrowth, most notably Proteus syndrome—a rare, progressive condition characterized by asymmetric overgrowth of bone, skin, and connective tissue; vascular malformations; and distinctive cerebriform connective tissue nevi. Modern molecular studies identify mosaic activating variants in AKT1 (c.49G&gt;A, p.E17K) as causative, arising post-zygotically and producing patchy distribution of affected tissues. Differential diagnoses include neurofibromatosis type 1, CLOVES syndrome (PIK3CA-related), and lymphatic/venous malformations; accurate classification hinges on clinical criteria plus, when feasible, tissue-based genetic testing.
    </p>

    <h3>[g] Pathology Signs/Signifiers of Illness</h3>
    <p>
        The illustration emphasizes craniofacial asymmetry, soft-tissue enlargement, and irregular dermal relief—features commonly documented in overgrowth syndromes. In a clinical context, correlates might include mandibular or zygomatic hypertrophy, dental malocclusion, and airway challenges; cutaneous thickening could suggest connective tissue nevi, while chest-wall deformity may relate to unilateral osseous overgrowth. As an artwork, however, the image functions didactically rather than diagnostically; no single representation suffices to determine a specific condition in an individual.
    </p>

    <h3>[h] Treatment</h3>
    <p>
        There is no curative therapy for Proteus syndrome; care is multidisciplinary and individualized. Orthopedic and maxillofacial interventions address functional compromise and pain, with conservative timing to account for progressive growth. Management of thromboembolic risk—heightened in Proteus syndrome—includes surveillance and anticoagulation when indicated. Compression, wound care, and physiotherapy support mobility and skin health. Targeted pathway modulation is under investigation: mTOR inhibition (e.g., sirolimus) has shown benefit in related PI3K/AKT pathway disorders, and early-phase studies of AKT inhibitors (e.g., miransertib/ARQ 092) suggest potential symptom reduction, though evidence remains evolving and off-label use requires specialist oversight.
    </p>

    <h3>[i] Social Determinants of Illness</h3>
    <p>
        Outcomes are shaped by access to specialized multidisciplinary centers, insurance coverage, and geographic proximity to tertiary care. Stigma and discrimination can limit education, employment, and social participation, compounding financial strain. Built-environment barriers, inadequate assistive services, and fragmented transition-of-care pathways further burden patients and families. Ethical, patient-centered communication and disability-inclusive policies are as critical as biomedical interventions in improving quality of life.
    </p>

    <h3>[j] References and Citations</h3>
    <ul>
        <li>National Institutes of Health, GARD: Proteus syndrome. https://rarediseases.info.nih.gov/diseases/7447/proteus-syndrome</li>
        <li>National Organization for Rare Disorders (NORD): Proteus Syndrome. https://rarediseases.org/rare-diseases/proteus-syndrome/</li>
        <li>Lindhurst, M. J., et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. Nature Genetics (2011). https://doi.org/10.1038/ng.908</li>
        <li>Cohen, M. M. Proteus syndrome: an expanded review. American Journal of Medical Genetics (2014). https://doi.org/10.1002/ajmg.a.36367</li>
        <li>Tibbles, J. A. R., & Cohen, M. M. The Proteus syndrome: the Elephant Man diagnosed. BMJ (1986). https://www.bmj.com/content/293/6556/683</li>
        <li>Daston, L., & Galison, P. Objectivity. Zone Books (2007). https://www.zonebooks.org/books/44-objectivity</li>
        <li>Garland-Thomson, R. Freakery: Cultural Spectacles of the Extraordinary Body. NYU Press (1996). https://nyupress.org/9780814730607/freakery/</li>
        <li>Wellcome Collection: Medical Illustration and the Body. https://wellcomecollection.org/</li>
    </ul>
</div>
</body>
</ht